Autran, Brigitte, 1954-....
Brigitte Autran
Autran, Brigitte,
Autran, B. (Brigitte)
VIAF ID: 27125752 (Personal)
Permalink: http://viaf.org/viaf/27125752
Preferred Forms
- 200 _ | ‡a Autran ‡b Brigitte
-
- 100 1 0 ‡a Autran, B. ‡q (Brigitte)
-
- 100 1 _ ‡a Autran, Brigitte,
- 100 1 _ ‡a Autran, Brigitte, ‡d 1954-....
- 100 0 _ ‡a Brigitte Autran
4xx's: Alternate Name Forms (8)
Works
Title | Sources |
---|---|
40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin | |
Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity | |
Caractérisation de la réponse lymphocytaire B mémoire contre le SARS-CoV-2 après infection ou vaccination | |
CARACTERISATION DES LYMPHOCYTES CD8 F O R TCD57+, ANALYSE BIOCHIMIQUE DE LA GLYCOPROTEINE INHIBITRICE DES FONCTIONS DE CYTOTOXICITE QU'ILS PRODUISENT | |
Caractérisation immunologique du réservoir cellulaire du VIH-1 en primo-infection et dans des modèles de contrôle spontané ou thérapeutique de l'infection | |
Caractérisation immunologique du syndrome de restauration immunitaire sous HAART au cours de la co-infection tuberculose-VIH1 | |
Characterization of pandemic influenza immune memory signature after vaccination or infection. | |
Characterization of protective immunodominant CD8 T cells in HIV infected long term non progressors | |
Chronic inflammation and immune activation in HIV controller patients : Relationships with the antiviral control and involvement of the IFN pathways. | |
Comprehensive Mass Cytometry Analysis of Cell Cycle, Activation, and Coinhibitory Receptors Expression in CD4 T Cells from Healthy and HIV-Infected Individuals | |
Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans | |
La cytométrie en flux | |
Développement d'une stratégie de vaccination thérapeutique antitumorale basée sur l'utilisation de lipopolyplexes à ARN ciblant les cellules dendritiques | |
Dissecting mechanisms underlying increased TLR7-mediated IFNα production in pDCs in physiological and pathophysiological settings : between sex differences and HIV-1-HCV co-infection | |
Early cellular and molecular changings and the injection site of vaccines : Caracterization of the innate and adaptive immune response after a recombining MVA injection. | |
Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial | |
Etude des paramètres immunologiques et immunopathologiques des patients infectés par le virus de l'immunodéficience humaine et asymptomatiques à long terme | |
Etude des réponses cellulaires th1 au cours des infections persistantes à VIH-1 et virus apparentés (VIH-2) ou associés (VHC) | |
Etude des réponses immunes spécifiques de l'herpès humain virus-8 (HHV-8) | |
Évaluation de combinaisons de ligands de PRR et de particules biodégradables pour la vaccination muqueuse | |
Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay | |
Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation | |
Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus | |
The French Committee for the prevention and control of influenza and the 2009 influenza pandemic: Lessons learnt | |
Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals | |
HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper Cells | |
HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses | |
The HIV infection and immune activation: "to fight and burn". | |
HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3. | |
Identical strength of the T cell responses against E2, nsP1 and capsid CHIKV proteins in recovered and chronic patients after the epidemics of 2005-2006 in La Reunion Island | |
Identification des mécanismes associés à une production élevée d'IFNa par les pDCs en réponse à TLR7 dans des contextes phyiologique et pathophysiologique : entre différences liées au sexe et co-infection par le VIH-1 et le VHC. | |
Immune characterization of the immune restoration syndrome (IRS) in TB-HIV co-infected patients. | |
Immunodeficiency in HIV infection and AIDS | |
Immunologic characterization and detection of innovative biomarkers of post-transplant lymphoproliferative diseases. | |
Increased carotid intima-media thickness is not associated with T-cell activation nor with cytomegalovirus in HIV-infected never-smoker patients | |
Inflammation chronique et hyperactivation du système immunitaire chez les patients HIV controllers : liens avec le contrôle antiviral et la mise en jeu de la voie des interférons | |
Influence of HIV-1 specific CD8 T cell responses on cellular HIV reservoir. | |
International symposium on therapeutic vaccines against HIV and cancers : 23-26 June 2002, Les Pensières, Veyrier-du-Lac, Annecy, France | |
Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection | |
L'immunologie cellulaire : approches expérimentales | |
Lymphocytes T et cellules dendritiques : mécanismes moléculaires intervenant lors d'interactions LAG-3 (CD223)/HLA de classe II | |
Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients | |
New aspects of T cells homeostasis during HIV infection revealed by microarrays analysis. | |
Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group | |
Nouveaux aspects de l' homéostasie lymphocytaire T au cours de l' infection VIH mis en évidence par microarrays | |
Operational research on emerging infectious diseases in Sub-saharan Africa. | |
Les paramètres immunologiques assiciés à la guérison spontanée et sous traitement de la phase aiguë de l'infection par VHC chez les patients coinfectés VHC/VIH | |
PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. | |
Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response | |
Perspectives for immunotherapy: which applications might achieve an HIV functional cure? | |
Plasticity of lymphoid compartments during HIV infection and treatments: hopes and limits | |
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study | |
Preclinical Evaluation of Trimannosylated mRNA Lipopolyplexes as Therapeutic Cancer Vaccines Targeting Dendritic-Cells. | |
Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial | |
Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1 | |
La recherche opérationnelle sur les maladies infectieuses à potentiel épidémique et menaçant en Afrique Sub-saharienne | |
Reconnaissance de variants d'un épitope viral par des lymphocytes T CD8+ induits par la vaccination de singes rhésus | |
RECONSTITUTION IMMUNITAIRE SOUS TRAITEMENTS ANTIRETROVIRAUX COMBINES AU COURS DE L'INFECTION PAR LE VIRUS DE L'IMMUNODEFICIENCE HUMAINE (VIH) | |
REPONSES T CYTOTOXIQUES AU VIH ET CONTROLE DES FONCTIONS DE CYTOTOXICITE EXERCE PAR LES CELLULES CD8+CD57+ | |
Rôle de l'antigène et de sa variabilité dans l'homéostasie des lymphocytes T périphériques | |
A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis | |
Role of the antigen and its variability on T cell homeostasis. | |
Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-α Production in Women | |
A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection | |
Studies on immunologic and immunopathologic parameters in HIV infected patients with long term non progression (LTNP). | |
Study of the immune responses induced by influenza vaccines h1n1pdm2009 in different types of immunosuppression. | |
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover | |
T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals | |
T-cell-mediated cytotoxicity against HIV in seropositive patients: a physiopathological approach | |
T-cell subset counting and the fight against AIDS: reflections over a 20-year struggle | |
Therapeutic immunization in HIV infection | |
Toward a cure for HIV--Seeking effective therapeutic vaccine strategies | |
Towards an HIV cure: a global scientific strategy | |
The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patients | |
Yeast-derived human immunodeficiency virus type 1 p55(gag) virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8(+) T cells by cross-presentation of DCs | |
Yellow fever vaccine booster : evaluation of the modifications of the WHO vaccine recommendations. |